Insider Transactions Reported by 9 Insiders of Lipocine Inc.

Symbol
LPCN on Nasdaq
Location
Salt Lake City, United States

There are no Buy or Sell transactions made by insiders since 30 Dec 2024

Lipocine Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Mahesh V. Patel Chief Executive Officer, Director $662,205 18 Dec 2025
Krista Fogarty Principal Accounting Officer $168,613 18 Dec 2025
MORGAN R. BROWN Chief Financial Officer $46,746 07 Dec 2021
John W. Higuchi Director $36,883 04 Jun 2025
Richard Dana Ono Director $36,883 04 Jun 2025
Jeffrey Fink Director $36,883 04 Jun 2025
George Nomikos Chief Medical Officer $33,200 01 Nov 2022
Spyros Papapetropoulos Director $22,956 04 Jun 2025
Jill M. Jene Director $22,956 04 Jun 2025

Recent Insider Transactions by Companies or Individuals for Lipocine Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.